{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:50:32Z","timestamp":1761511832812},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,1,1]],"date-time":"2002-01-01T00:00:00Z","timestamp":1009843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Pharmaceutical Association (1996)"],"published-print":{"date-parts":[[2002,1]]},"DOI":"10.1331\/108658002763538107","type":"journal-article","created":{"date-parts":[[2003,6,17]],"date-time":"2003-06-17T16:53:18Z","timestamp":1055868798000},"page":"74-82","source":"Crossref","is-referenced-by-count":10,"title":["Meeting the Therapeutic Challenge of the Patient With Osteoarthritis"],"prefix":"10.1016","volume":"42","author":[{"given":"Cathryn","family":"Todd","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1331\/108658002763538107_bb0010","first-page":"433","article-title":"Arthritis prevalence and activity limitations\u2014United States, 1990","volume":"43","year":"1994","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1331\/108658002763538107_bb0015","first-page":"1795","article-title":"Osteoarthritis: Current concepts in diagnosis and management","volume":"61","author":"Manek","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1331\/108658002763538107_bb0020","series-title":"Harrison's Principles of Internal Medicine","first-page":"1935","article-title":"Osteoarthritis","author":"Brandt","year":"1998"},{"key":"10.1331\/108658002763538107_bb0025","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/art.1780400420","article-title":"Risk factors for incident radiographic knee osteoarthritis in the elderly. The Framingham Study","volume":"40","author":"Felson","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"suppl 2","key":"10.1331\/108658002763538107_bb0030","first-page":"174","article-title":"Nonopioid effect of tramadol in the Formalin Test [abstract]","volume":"6","author":"Aurilio","year":"1998","journal-title":"J Musculoskelet Pain"},{"key":"10.1331\/108658002763538107_bb0035","series-title":"Textbook of Rheumatology","first-page":"1383","article-title":"Clinical features of osteoarthritis","author":"Solomon","year":"1997"},{"key":"10.1331\/108658002763538107_bb0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0140-6736(97)07226-7","article-title":"Osteoarthritis","volume":"350","author":"Creamer","year":"1997","journal-title":"Lancet"},{"key":"10.1331\/108658002763538107_bb0045","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V","article-title":"Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States","volume":"41","author":"Lawrence","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1331\/108658002763538107_bb0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1098-3597(99)90012-1","article-title":"Osteoarthritis: A review","volume":"2","author":"Simon","year":"1999","journal-title":"Clin Cornerstone"},{"key":"10.1331\/108658002763538107_bb0055","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/art.1780290816","article-title":"Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee","volume":"29","author":"Altman","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1331\/108658002763538107_bb0060","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/art.1780381103","article-title":"Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology","volume":"38","author":"Hochberg","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"suppl 3","key":"10.1331\/108658002763538107_bb0065","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2165\/00003495-199600523-00004","article-title":"Mechanisms of joint destruction, pain and disability in osteoarthritis","volume":"52","author":"Pinals","year":"1996","journal-title":"Drugs"},{"key":"10.1331\/108658002763538107_bb0070","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","article-title":"Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis","volume":"43","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1331\/108658002763538107_bb0075","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/art.1780381104","article-title":"Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee","volume":"38","author":"Hochberg","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1331\/108658002763538107_bb0080","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/anr.1780321108","article-title":"Efficacy of physical conditioning exercise in patients with rheumatoid arthritis and osteoarthritis","volume":"32","author":"Minor","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1331\/108658002763538107_bb0085","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0889-857X(05)70075-2","article-title":"Exercise in the treatment of osteoarthritis","volume":"25","author":"Minor","year":"1999","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1331\/108658002763538107_bb0090","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1532-5415.2000.tb04781.x","article-title":"Exercise and weight loss in obese older adults with knee osteoarthritis: A preliminary study","volume":"48","author":"Messier","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"10.1331\/108658002763538107_bb0095","first-page":"59","article-title":"Evaluation of acetaminophen in the management of osteoarthritis of the knee","volume":"34","author":"Amadio","year":"1983","journal-title":"Curr Ther Res"},{"key":"10.1331\/108658002763538107_bb0100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJM199107113250203","article-title":"Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee","volume":"325","author":"Bradley","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1331\/108658002763538107_bb0105","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/art.1780360904","article-title":"Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee","volume":"36","author":"Williams","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1331\/108658002763538107_bb0110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0304-3959(94)90001-9","article-title":"Acetaminophen blocks spinal hyperalgesia induced by NMDA and substance P","volume":"57","author":"Bj\u00f6rkman","year":"1994","journal-title":"Pain"},{"issue":"suppl 103","key":"10.1331\/108658002763538107_bb0115","first-page":"1","article-title":"Central antinociceptive effects of non-steroidal anti-inflammatory drugs and paracetamol. Experimental studies in the rat","volume":"39","author":"Bjorkman","year":"1995","journal-title":"Acta Anaesthesiol Scand"},{"key":"10.1331\/108658002763538107_bb0120","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1001\/jama.1994.03520230055038","article-title":"Association of acetaminophen hepatotoxicity with fasting and ethanol use","volume":"272","author":"Whitcomb","year":"1994","journal-title":"JAMA"},{"key":"10.1331\/108658002763538107_bb0125","first-page":"1662","article-title":"Synovial inflammation in patients with early osteoarthritis of the knee","volume":"17","author":"Myers","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1331\/108658002763538107_bb0130","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1002\/art.1780401105","article-title":"Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis. Support for the concept of \u201cresponders\u201d and \u201cnonresponders.\u201d","volume":"40","author":"Walker","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1331\/108658002763538107_bb0135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-114-4-257","article-title":"Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons","volume":"114","author":"Griffin","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1331\/108658002763538107_bb0140","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/oxfordjournals.aje.a117469","article-title":"Nonsteroidal anti-inflammatory drugs and the incidence of hospitalizations for peptic ulcer disease in elderly persons","volume":"141","author":"Smalley","year":"1995","journal-title":"Am J Epidemiol"},{"key":"10.1331\/108658002763538107_bb0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-109-5-359","article-title":"Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons","volume":"109","author":"Griffin","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1331\/108658002763538107_bb0150","first-page":"708","article-title":"Nonsteroidal antiinflammatory drug discontinuation in patients with osteoarthritis","volume":"22","author":"Scholes","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1331\/108658002763538107_bb0155","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1331\/108658002763538107_bb0160","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/archinte.1987.00370120029008","article-title":"Nonsteroidal anti-inflammatory drug gastropathy. Recognition and response","volume":"147","author":"Roth","year":"1987","journal-title":"Arch Intern Med"},{"key":"10.1331\/108658002763538107_bb0165","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJM199412223312502","article-title":"Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs","volume":"331","author":"Perneger","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1331\/108658002763538107_bb0170","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00045391-200007020-00005","article-title":"The role of analgesics in the management of osteoarthritis pain","volume":"7","author":"Brandt","year":"2000","journal-title":"Am J Ther"},{"key":"10.1331\/108658002763538107_bb0175","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/106002809703100214","article-title":"Nonnarcotic analgesics: Prevalence and estimated economic impact of toxicities","volume":"31","author":"McGoldrick","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1331\/108658002763538107_bb0180","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2125.1993.tb04169.x","article-title":"Non-steroidal anti-inflammatory drugs and hypertension in the elderly: A community-based cross-sectional study","volume":"35","author":"Johnson","year":"1993","journal-title":"Br J Clin Pharmacol"},{"key":"10.1331\/108658002763538107_bb0185","first-page":"22","article-title":"Effect of pain and nonsteroidal analgesics on blood pressure","volume":"98","author":"Chawla","year":"1999","journal-title":"WMJ"},{"issue":"suppl 5A","key":"10.1331\/108658002763538107_bb0190","doi-asserted-by":"crossref","first-page":"42S","DOI":"10.1016\/0002-9343(91)90485-G","article-title":"Nonsteroidal anti-inflammatory drugs and antihypertensives","volume":"90","author":"Houston","year":"1991","journal-title":"Am J Med"},{"key":"10.1331\/108658002763538107_bb0195","series-title":"The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","first-page":"1","year":"1997"},{"key":"10.1331\/108658002763538107_bb0200","first-page":"66","article-title":"Management of arthritis","volume":"2","author":"Kellick","year":"1998","journal-title":"Lippincotts Prim Care Pract"},{"key":"10.1331\/108658002763538107_bb0205","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1093\/ajhp\/56.11.1079","article-title":"Editorial: Responsible use of analgesics","volume":"56","author":"Setter","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"10.1331\/108658002763538107_bb0210","series-title":"Osteoarthritis","first-page":"282","article-title":"Economic considerations in the use of nonsteroidal anti-inflammatory drugs","author":"Ray","year":"1998"},{"key":"10.1331\/108658002763538107_bb0215","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/1529-0131(200001)43:1<4::AID-ANR2>3.0.CO;2-V","article-title":"Basic biology and clinical application of specific cyclooxygenase-2 inhibitors","volume":"43","author":"Crofford","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1331\/108658002763538107_bb0220","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1001\/jama.282.20.1921","article-title":"Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis. A randomized controlled trial","volume":"282","author":"Simon","year":"1999","journal-title":"JAMA"},{"key":"10.1331\/108658002763538107_bb0225","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJM199906243402516","article-title":"Gastropathy due to celecoxib, a cyclooxygenase-2 inhibitor","volume":"340","author":"Mohammed","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1331\/108658002763538107_bb0230","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0009-9236(99)70056-1","article-title":"Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects","volume":"66","author":"Rossat","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1331\/108658002763538107_bb0235","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study. A randomized controlled trial","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"10.1331\/108658002763538107_bb0240","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1001\/jama.282.20.1961","article-title":"COX-1\u2013sparing NSAIDs\u2014is the enthusiasm justified?","volume":"282","author":"Peterson","year":"1999","journal-title":"JAMA"},{"key":"10.1331\/108658002763538107_bb0245","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1345\/aph.18415","article-title":"The cyclooxygenase-2 inhibitors: Safety and effectiveness","volume":"33","author":"Kaplan-Machlis","year":"1999","journal-title":"Ann Pharmacother"},{"key":"10.1331\/108658002763538107_bb0250","series-title":"Meeting documents","author":"FDA Arthritis Advisory Committee","year":"2001"},{"key":"10.1331\/108658002763538107_bb0255","first-page":"271","article-title":"The basic science aspect of tramadol hydrochloride","volume":"3","author":"Raffa","year":"1996","journal-title":"Pain Rev"},{"key":"10.1331\/108658002763538107_bb0260","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0376-8716(99)00041-1","article-title":"A postmarketing surveillance program to monitor Ultram (tramadol hydrochloride) abuse in the United States","volume":"57","author":"Cicero","year":"1999","journal-title":"Drug Alcohol Depend"},{"key":"10.1331\/108658002763538107_bb0265","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF03258480","article-title":"Tramadol versus dextropropoxyphene in the treatment of osteoarthritis","volume":"8","author":"Jensen","year":"1994","journal-title":"Drug Invest"},{"key":"10.1331\/108658002763538107_bb0270","series-title":"Curr Ther Res","first-page":"113","article-title":"Tramadol for the treatment of joint pain associated with osteoarthritis: A randomized, double-blind, placebo-controlled trial","author":"Fleischmann","year":"2001"},{"issue":"suppl 3","key":"10.1331\/108658002763538107_bb0275","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00003495-199600523-00007","article-title":"Pharmacology and clinical experience with tramadol in osteoarthritis","volume":"52","author":"Katz","year":"1996","journal-title":"Drugs"},{"key":"10.1331\/108658002763538107_bb0280","first-page":"1358","article-title":"Efficacy and safety of tramadol HCl in breakthrough musculoskeletal pain attributed to osteoarthritis","volume":"25","author":"Roth","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1331\/108658002763538107_bb0285","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1002\/1529-0131(199907)42:7<1370::AID-ANR10>3.0.CO;2-T","article-title":"Tramadol allows reduction of naproxen dose among patients with naproxen-responsive osteoarthritis pain: A randomized, double-blind, placebo-controlled study","volume":"42","author":"Schnitzer","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1331\/108658002763538107_bb0290","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/106002809703100208","article-title":"Possible serotonin syndrome associated with tramadol and sertraline coadministration","volume":"31","author":"Mason","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1331\/108658002763538107_bb0295","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/ajhp\/54.6.643","article-title":"Tramadol: A new centrally acting analgesic","volume":"54","author":"Lewis","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"10.1331\/108658002763538107_bb0300","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.1997.03550200037026","article-title":"Seizures reported with tramadol","volume":"278","author":"Kahn","year":"1997","journal-title":"JAMA"},{"key":"10.1331\/108658002763538107_bb0305","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1592\/phco.20.7.629.35174","article-title":"Incidence of first-time idiopathic seizures in users of tramadol","volume":"20","author":"Gasse","year":"2000","journal-title":"Pharmacotherapy"},{"key":"10.1331\/108658002763538107_bb0310","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1592\/phco.19.1.88.30515","article-title":"Slowing the initial titration rate of tramadol improves tolerability","volume":"19","author":"Ruoff","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1331\/108658002763538107_bb0315","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1365-2710.1999.00203.x","article-title":"Slowing the titration rate of tramadol HCI reduces the incidence of discontinuation due to nausea and\/or vomiting: A double-blind randomized trial","volume":"24","author":"Petrone","year":"1999","journal-title":"J Clin Pharm Ther"},{"key":"10.1331\/108658002763538107_bb0320","series-title":"Physicians\u2019 Desk Reference","first-page":"2398","article-title":"Ultram (tramadol hydrochloride tablets) [prescribing information]","author":"Ortho-McNeil Pharmaceutical","year":"2001"},{"key":"10.1331\/108658002763538107_bb0325","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2165\/00002018-199921040-00004","article-title":"Risk\u2013benefit assessment of opioids in chronic noncancer pain","volume":"21","author":"Bannwarth","year":"1999","journal-title":"Drug Saf"},{"key":"10.1331\/108658002763538107_bb0330","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/00001503-199810000-00016","article-title":"Side-effects of opioids in chronic pain treatment","volume":"11","author":"Lawlor","year":"1998","journal-title":"Curr Opin Anaesthesiol"},{"key":"10.1331\/108658002763538107_bb0335","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2165\/00003495-199651050-00002","article-title":"Opioid analgesics: Comparative features and prescribing guidelines","volume":"51","author":"Cherny","year":"1996","journal-title":"Drugs"},{"key":"10.1331\/108658002763538107_bb0340","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0025-7125(05)70133-4","article-title":"Opioid use in the management of chronic pain","volume":"83","author":"Savage","year":"1999","journal-title":"Med Clin North Am"},{"key":"10.1331\/108658002763538107_bb0345","series-title":"Goodman and Gilman's the Pharmacological Basis of Therapeutics","author":"Gilman","year":"1990"},{"key":"10.1331\/108658002763538107_bb0350","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0885-3924(97)00082-1","article-title":"Transdermal fentanyl versus sustained-release oral morphine in cancer pain: Preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group","volume":"13","author":"Ahmedzai","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"10.1331\/108658002763538107_bb0355","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0304-3959(96)03254-X","article-title":"Transdermal fentanyl in the long-term treatment of cancer pain: A prospective study of 50 patients with advanced cancer of the gastrointestinal tract or the head and neck region","volume":"69","author":"Grond","year":"1997","journal-title":"Pain"},{"key":"10.1331\/108658002763538107_bb0360","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0002-9343(84)80101-1","article-title":"Combination analgesics","volume":"77","author":"Beaver","year":"1984","journal-title":"Am J Med"},{"key":"10.1331\/108658002763538107_bb0365","series-title":"Chronic Pain Management in the Long-Term Care Setting. Clinical Practice Guideline","author":"American Medical Directors Association","year":"1999"},{"issue":"suppl 3","key":"10.1331\/108658002763538107_bb0370","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0049-0172(10)80023-X","article-title":"Capsaicin cream 0.025% as monotherapy for osteoarthritis: A double-blind study","volume":"23","author":"Altman","year":"1994","journal-title":"Semin Arthritis Rheum"},{"key":"10.1331\/108658002763538107_bb0375","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF00196108","article-title":"The effectiveness of topically applied capsaicin: A meta-analysis","volume":"46","author":"Zhang","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1331\/108658002763538107_bb0380","first-page":"383","article-title":"Treatment of arthritis with topical capsaicin: A double-blind trial","volume":"13","author":"Deal","year":"1991","journal-title":"Clin Ther"},{"key":"10.1331\/108658002763538107_bb0385","first-page":"2423","article-title":"Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee","volume":"26","author":"Houpt","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1331\/108658002763538107_bb0390","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0889-857X(05)70074-0","article-title":"Nutraceuticals as therapeutic agents in osteoarthritis. The role of glucosamine, chondroitin sulfate, and collagen hydrolysate","volume":"25","author":"Deal","year":"1999","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1331\/108658002763538107_bb0395","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0140-6736(00)03610-2","article-title":"Long-term effects of glucosamine sulphate on osteoarthritis progression: A randomised, placebo-controlled clinical trial","volume":"357","author":"Reginster","year":"2001","journal-title":"Lancet"},{"key":"10.1331\/108658002763538107_bb0400","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/milmed\/164.2.85","article-title":"Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: A randomized, double-blind, placebo-controlled pilot study","volume":"164","author":"Leffler","year":"1999","journal-title":"Mil Med"},{"key":"10.1331\/108658002763538107_bb0405","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/jama.283.11.1483","article-title":"Glucosamine and chondroitin for treating symptoms of osteoarthritis. Evidence is widely touted but incomplete","volume":"283","author":"Towheed","year":"2000","journal-title":"JAMA"},{"key":"10.1331\/108658002763538107_bb0410","first-page":"565","article-title":"Intra-articular hyaluronic acid injections for knee osteoarthritis","volume":"62","author":"Wen","year":"2000","journal-title":"Am Fam Physician"},{"key":"10.1331\/108658002763538107_bb0415","first-page":"501","article-title":"Therapeutic effect of intra-articular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee","volume":"20","author":"Namiki","year":"1982","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1331\/108658002763538107_bb0420","first-page":"495","article-title":"Hyaluronic acid therapy","volume":"49","author":"Rosier","year":"2000","journal-title":"Instr Course Lect"},{"key":"10.1331\/108658002763538107_bb0425","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/bmj.320.7238.820","article-title":"Total knee replacement: The joint of the decade. A successful operation, for which there's a large unmet need","volume":"320","author":"Moran","year":"2000","journal-title":"BMJ"},{"key":"10.1331\/108658002763538107_bb0430","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/rheumatology\/37.9.946","article-title":"Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: Results of the Safety and Efficacy Large-Scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis","volume":"37","author":"Dequeker","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1331\/108658002763538107_bb0435","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.4065\/74.11.1095","article-title":"Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: A randomized controlled trial","volume":"74","author":"Bensen","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"10.1331\/108658002763538107_bb0440","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1592\/phco.19.16.1269.30879","article-title":"Evaluation of the functional status aspects of health-related quality of life of patients with osteoarthritis treated with celecoxib","volume":"19","author":"Zhao","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1331\/108658002763538107_bb0445","first-page":"2438","article-title":"Effect of specific COX-2 inhibition in osteoarthritis of the knee: A 6-week double blind, placebo controlled pilot study of rofecoxib","volume":"26","author":"Ehrich","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1331\/108658002763538107_bb0450","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/rheumatology\/37.9.937","article-title":"Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients","volume":"37","author":"Hawkey","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1331\/108658002763538107_bb0455","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1001\/archinte.160.12.1781","article-title":"A randomized trial of the efficacy and tolerability of the COX-2 inhibitor rofecoxib vs ibuprofen in patients with osteoarthritis. Rofecoxib\/Ibuprofen Comparator Study Group","volume":"160","author":"Day","year":"2000","journal-title":"Arch Intern Med"}],"container-title":["Journal of the American Pharmaceutical Association (1996)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1086580215303272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1086580215303272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T21:25:16Z","timestamp":1584825916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1086580215303272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,1]]}},"alternative-id":["S1086580215303272"],"URL":"https:\/\/doi.org\/10.1331\/108658002763538107","relation":{},"ISSN":["1086-5802"],"issn-type":[{"value":"1086-5802","type":"print"}],"subject":[],"published":{"date-parts":[[2002,1]]}}}